PMID- 24725463 OWN - NLM STAT- MEDLINE DCOM- 20140826 LR - 20221207 IS - 1475-2840 (Electronic) IS - 1475-2840 (Linking) VI - 13 DP - 2014 Apr 12 TI - Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study. PG - 77 LID - 10.1186/1475-2840-13-77 [doi] AB - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a major cardiovascular disease (CVD) risk factor. Identification of genetic risk factors for CVD is important to understand disease risk. Two recent genome-wide association study (GWAS) meta-analyses in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium detected CVD-associated loci. METHODS: Variants identified in CHARGE were tested for association with CVD phenotypes, including vascular calcification, and conventional CVD risk factors, in the Diabetes Heart Study (DHS) (n = 1208; >80% T2DM affected). This included 36 genotyped or imputed single nucleotide polymorphisms (SNPs) from DHS GWAS data. 28 coding SNPs from 14 top CHARGE genes were also identified from exome sequencing resources and genotyped, along with 209 coding variants from the Illumina HumanExome BeadChip genotype data in the DHS were also tested. Genetic risk scores (GRS) were calculated to evaluate the association of combinations of variants with CVD measures. RESULTS: After correction for multiple comparisons, none of the CHARGE SNPs were associated with vascular calcification (p < 0.0014). Multiple SNPs showed nominal significance with calcification, including rs599839 (PSRC1, p = 0.008), rs646776 (CELSR2, p = 0.01), and rs17398575 (PIK3CG, p = 0.009). Additional COL4A2 and CXCL12 SNPs were nominally associated with all-cause or CVD-cause mortality. Three SNPs were significantly or nominally associated with serum lipids: rs3135506 (Ser19Trp, APOA5) with triglycerides (TG) (p = 5x10(-5)), LDL (p = 0.00070), and nominally with high density lipoprotein (HDL) (p = 0.0054); rs651821 (5'UTR, APOA5) with increased TGs (p = 0.0008); rs13832449 (splice donor, APOC3) associated with decreased TGs (p = 0.0015). Rs45456595 (CDKN2A, Gly63Arg), rs5128 (APOC3, 3'UTR), and rs72650673 (SH2B3, Glu400Lys) were nominally associated with history of CVD, subclinical CVD, or CVD risk factors (p < 0.010). From the exome chip, rs3750103 (CHN2, His204Arg/His68Arg) with carotid intima-medial thickness (IMT) (p = 3.9x10(-5)), and rs61937878 (HAL, Val549Met) with infra-renal abdominal aorta CP (AACP) (p = 7.1x10(-5)). The unweighted GRS containing coronary artery calcified plaque (CAC) SNPs was nominally associated with history of prior CVD (p = 0.033; OR = 1.09). The weighted GRS containing SNPs was associated with CAC and myocardial infarction (MI) was associated with history of MI (p = 0.026; OR = 1.15). CONCLUSIONS: Genetic risk factors for subclinical CVD in the general population (CHARGE) were modestly associated with T2DM-related risk factors and CVD outcomes in the DHS. FAU - Adams, Jeremy N AU - Adams JN FAU - Raffield, Laura M AU - Raffield LM FAU - Freedman, Barry I AU - Freedman BI FAU - Langefeld, Carl D AU - Langefeld CD FAU - Ng, Maggie C Y AU - Ng MC FAU - Carr, J Jeffrey AU - Carr JJ FAU - Cox, Amanda J AU - Cox AJ FAU - Bowden, Donald W AU - Bowden DW AD - Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. dbowden@wakehealth.edu. LA - eng GR - R01 HL092301/HL/NHLBI NIH HHS/United States GR - R01 NS058700/NS/NINDS NIH HHS/United States GR - R01 HL67348/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20140412 PL - England TA - Cardiovasc Diabetol JT - Cardiovascular diabetology JID - 101147637 SB - IM MH - Aged MH - Cardiovascular Diseases/diagnosis/epidemiology/*genetics MH - Diabetes Mellitus, Type 2/diagnosis/epidemiology/*genetics MH - Female MH - Follow-Up Studies MH - Genetic Variation/*genetics MH - Genome-Wide Association Study/*methods MH - Humans MH - Male MH - Middle Aged MH - Polymorphism, Single Nucleotide/*genetics MH - White People/*genetics PMC - PMC4021556 EDAT- 2014/04/15 06:00 MHDA- 2014/08/27 06:00 PMCR- 2014/04/12 CRDT- 2014/04/15 06:00 PHST- 2014/01/14 00:00 [received] PHST- 2014/03/26 00:00 [accepted] PHST- 2014/04/15 06:00 [entrez] PHST- 2014/04/15 06:00 [pubmed] PHST- 2014/08/27 06:00 [medline] PHST- 2014/04/12 00:00 [pmc-release] AID - 1475-2840-13-77 [pii] AID - 10.1186/1475-2840-13-77 [doi] PST - epublish SO - Cardiovasc Diabetol. 2014 Apr 12;13:77. doi: 10.1186/1475-2840-13-77.